Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue
about
Developments in the identification of glycan biomarkers for the detection of cancerMALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarraysModification of glycosylation mediates the invasive properties of murine hepatocarcinoma cell lines to lymph nodes.Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry.Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma.Site-specific analysis of changes in the glycosylation of proteins in liver cirrhosis using data-independent workflow with soft fragmentation.Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.Differential N-Glycosylation Patterns in Lung Adenocarcinoma TissueGlycoprotein disease markers and single protein-omicsSite-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinomaGlycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes.Intrinsic hepatocyte dedifferentiation is accompanied by upregulation of mesenchymal markers, protein sialylation and core alpha 1,6 linked fucosylationEnrichment strategies in glycomics-based lung cancer biomarker development.Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.Cell surface protein glycosylation in cancer.Glycosylation and liver cancer.Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.Visual detection of serum asialohaptoglobin by plasmonic sandwich ELLSA--a new platform for cirrhosis diagnosis.Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.Protein and site specificity of fucosylation in liver-secreted glycoproteins.Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC.Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma.
P2860
Q27026715-A046F268-EC33-4CB5-9122-B1AC55E72AF0Q28542741-8F6E2596-6E97-408B-B141-195AD57AD600Q34804402-3114A335-BB1E-40B9-A7AC-BA12EFC269EEQ35649524-559BB90B-2B31-4295-BF15-BF51654E35CEQ35821161-8F18EA6E-C5FE-4C64-AC55-764A2F86E3F8Q36155480-F636BDE5-D656-4384-A52F-E35A2A35176EQ36185188-54F67B85-C158-411B-A055-769BF4F14F89Q36249639-7C267E20-1FF2-478A-A3D7-D5ADF9F9659CQ36278033-8A0EEC26-DCB7-4798-A21C-0272A4655CC7Q36742398-5D73D042-ACF8-482F-912A-B9566A3A9489Q36832489-110DD27E-50D4-44D7-A7F0-D069DF5713CDQ36919273-CC6806FE-984D-427A-8A1F-19B69E1FD541Q37027426-A90A0042-0463-4735-8AA9-B98BC435E970Q37446239-C901C226-335B-4DB4-AE49-597E81C0B976Q37641583-E45178C6-32DE-48D6-818E-A74D93CBEB88Q38171440-BE3E69C2-D4E2-46F6-96D3-0B94EF9E0BB5Q38366329-326FB4BD-F34B-445B-BCED-4CEAF12B6093Q38744673-39A9C543-B77C-42EA-A385-864E8E8B02FFQ38968841-C7B5A328-BC93-4E87-8FB7-8620ECBAD386Q39535354-2F28BF00-01F1-4BAF-80A9-D477C2A4E52CQ41123248-2EF9FB80-392F-446E-AA91-0D4681E6DFE9Q41684858-BF90549B-BF4A-4E09-9E88-9A6680164572Q42185516-A6AF4144-115E-411C-B836-F5D6AC28E24EQ46512130-EFA7E2BF-7E08-445A-8BA9-04377A7DB324Q49590854-A16B5AE8-3964-4756-9867-035E4BB758E4
P2860
Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Increased levels of tetra-ante ...... epatocellular carcinoma tissue
@ast
Increased levels of tetra-ante ...... epatocellular carcinoma tissue
@en
type
label
Increased levels of tetra-ante ...... epatocellular carcinoma tissue
@ast
Increased levels of tetra-ante ...... epatocellular carcinoma tissue
@en
prefLabel
Increased levels of tetra-ante ...... epatocellular carcinoma tissue
@ast
Increased levels of tetra-ante ...... epatocellular carcinoma tissue
@en
P2093
P2860
P1476
Increased levels of tetra-ante ...... epatocellular carcinoma tissue
@en
P2093
Alex Koszycki
Anand Mehta
Eiji Miyoshi
Hongyan Liang
Katsuhisa Noda
Lucy Rodemich-Betesh
Mary Ann Comunale
Mengjun Wang
Timothy Block
P2860
P304
P356
10.1158/1055-9965.EPI-11-1183
P577
2012-04-06T00:00:00Z